Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIOLASE Inc (NASDAQ:BIOL)

0.60
Delayed Data
As of Aug 18
 +0.003 / +0.50%
Today’s Change
0.48
Today|||52-Week Range
1.98
-57.14%
Year-to-Date
No recent news for BIOLASE Inc.

Today’s Trading

Previous close0.60
Today’s open0.58
Day’s range0.58 - 0.60
Volume127,747
Average volume (3 months)86,365
Market cap$45.6M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+17.14%
Earnings growth (this year)+24.14%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+7.68%
P/E ratioNM
Price/Sales1.64
Price/Book1.84

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...+0.05+4.55%
PDEXPro-Dex Inc+0.39+6.28%
XRAYDentsply Sirona Inc-0.32-0.60%
ALGNAlign Technology Inc-0.75-0.44%
Data as of 7:59pm ET, 08/18/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$51.8M
Annual profit (last year)-$15.4M
Net profit margin-29.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Harold C. Flynn
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts